Flora Growth Corp.

FLGC

CA3397642016

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
1.23 ^USD	-6.11%		-8.89%	-8.89%

May. 16	Roth MKM Adjusts Price Target on Flora Growth to $6 From $7, Maintains Buy Rating	MT
May. 15	Transcript : Flora Growth Corp., Q1 2024 Earnings Call, May 15, 2024

Flora Growth Corp. Provides Financial Guidance for the Second Half of 2021

August 19, 2021 at 04:05 pm EDT

Flora Growth Corp. provided financial guidance for the second half of 2021. For the second half, the company anticipates revenue to be in the range of $9-11 million.

Latest news about Flora Growth Corp.

Roth MKM Adjusts Price Target on Flora Growth to $6 From $7, Maintains Buy Rating	May. 16	MT
Transcript : Flora Growth Corp., Q1 2024 Earnings Call, May 15, 2024	May. 15
Flora Growth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Flora Growth Insider Bought Shares Worth $999,999, According to a Recent SEC Filing	Apr. 09	MT
Flora Growth Completes $3.2 Million Common Stock Offering	Apr. 09	MT
Flora Growth Corp. announced that it has received $3.23 million in funding from Yt Research Inc	Apr. 07	CI
Top Premarket Decliners	Apr. 04	MT
Flora Growth Corp. agreed to acquire TruHC Pharma GmbH for $6.4 million.	Mar. 31	CI
Flora Growth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data	Mar. 25	MT
US Futures Dip Lower in Monday's Premarket to Open Shortened Week, Ahead of Housing Data, Bostic Speech	Mar. 25	MT
Top Premarket Gainers	Jan. 11	MT
Flora Growth Corp. Announces the Resignation Thomas Solomon as Director	Dec. 06	CI
Tranche Update on Flora Growth Corp.'s Equity Buyback Plan announced on June 16, 2022.	Nov. 08	CI
Flora Growth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Lisan Farma Colombia LLC completed the acquisition of majority stake in six companies from Flora Growth Corp. (NasdaqCM : FLGC).	Oct. 31	CI
Lifeist Wellness Terminated Agreement for Sale of Australian Vapes; Involved Nasdaq's Flora Growth Corp.	23-10-25	MT
North American Morning Briefing : Google Parent's -2-	23-10-25	DJ
Flora Growth Corp. (NasdaqCM : FLGC) cancelled the acquisition of Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV : LFST).	23-10-19	CI
Flora Growth Corp. Announces the Resignation of Juan Carlos Roa Gomez as Director	23-10-16	CI
Flora Growth Corp. Announces Transition of Hussein Rakine from Director to Special Advisor	23-10-02	CI
Top Premarket Gainers	23-09-25	MT
Wall Street Set to Open Marginally Lower as Fed Kicks Off September Policy Meeting	23-09-19	MT
Flora Growth Corp. announced that it expects to receive $2.738 million in funding	23-09-18	CI
Lifeist Wellness Selling Australian Vaporizers Subsidiary to Flora Growth	23-09-18	MT

Flora Growth Corp. operates as a lifestyle brand in the United States and international pharmaceutical distributor focused on therapeutics, starting with medical cannabis. The Company serves approximately 50 states and 28 countries. The Companyâs JustCBD is a consumer-packaged goods brand. JustCBD. JustCBD offering consists of over 350 products across 15 categories, including cannabidiol (CBD) gummies, topicals, tinctures, and vape products. JustCBD products are available for purchase in smoke and vape shops, clinics, spas, and pet stores, as well as other independent non-traditional retail channels. The Companyâs Vessel is a cannabis accessory and technology brand servicing the United States and Canada through direct-to-consumer and retail sales. Vessel's products include cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herb categories, which are sold to consumers, dispensaries, smoke shops and cannabis brands.

Sector

Healthcare Facilities & Services

Calendar

2024-08-13 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Flora Growth Corp.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.23 USD

Average target price

5.5 USD

Spread / Average Target

+347.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Farming

	1st Jan change	Capi.
FLORA GROWTH CORP.	-8.89%	16.74M
CRUCIAL INNOVATIONS CORP.	-.--%	339M
AYR WELLNESS INC.	+52.26%	299M
ASCEND WELLNESS HOLDINGS, INC.	+35.05%	279M
INTERCURE LTD.	+168.19%	152M
JUSHI HOLDINGS INC.	+45.65%	138M
THE CANNABIST COMPANY HOLDINGS INC.	-41.95%	128M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	122M
4FRONT VENTURES CORP.	+34.62%	118M
BAKHU HOLDINGS, CORP.	+100.00%	60.26M

Medical Farming